BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 22992418)

  • 1. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
    Otani Y; Kijima T; Kohmo S; Oishi S; Minami T; Nagatomo I; Takahashi R; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Fujii N; Kumanogoh A
    FEBS Lett; 2012 Oct; 586(20):3639-44. PubMed ID: 22992418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of adhesion molecules and chemokine receptor CXCR4 (CD184) in small cell lung cancer.
    Hartmann TN; Burger M; Burger JA
    J Biol Regul Homeost Agents; 2004; 18(2):126-30. PubMed ID: 15471215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR4 chemokine receptor and integrin signaling co-operate in mediating adhesion and chemoresistance in small cell lung cancer (SCLC) cells.
    Hartmann TN; Burger JA; Glodek A; Fujii N; Burger M
    Oncogene; 2005 Jun; 24(27):4462-71. PubMed ID: 15806155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional expression of CXCR4 (CD184) on small-cell lung cancer cells mediates migration, integrin activation, and adhesion to stromal cells.
    Burger M; Glodek A; Hartmann T; Schmitt-Gräff A; Silberstein LE; Fujii N; Kipps TJ; Burger JA
    Oncogene; 2003 Nov; 22(50):8093-101. PubMed ID: 14603250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of high expression levels of CXCR4 in tumor growth, vascularization, and metastasis.
    Darash-Yahana M; Pikarsky E; Abramovitch R; Zeira E; Pal B; Karplus R; Beider K; Avniel S; Kasem S; Galun E; Peled A
    FASEB J; 2004 Aug; 18(11):1240-2. PubMed ID: 15180966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypic knockout of CXCR4 by a novel recombinant protein TAT/54R/KDEL inhibits tumors metastasis.
    Ma WF; Du J; Fu LP; Fang R; Chen HY; Cai SH
    Mol Cancer Res; 2009 Oct; 7(10):1613-21. PubMed ID: 19825996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of CXC chemokine receptor-4 enhances the pulmonary metastatic potential of murine B16 melanoma cells.
    Murakami T; Maki W; Cardones AR; Fang H; Tun Kyi A; Nestle FO; Hwang ST
    Cancer Res; 2002 Dec; 62(24):7328-34. PubMed ID: 12499276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
    Li RJ; Zhao LJ; Zhan ZL; Lü X; Gong LL; Wang P
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):532-5. PubMed ID: 22490156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction between neoplastic cells and cancer-associated fibroblasts through the CXCL12/CXCR4 axis: role in non-small cell lung cancer tumor proliferation.
    Wald O; Izhar U; Amir G; Kirshberg S; Shlomai Z; Zamir G; Peled A; Shapira OM
    J Thorac Cardiovasc Surg; 2011 Jun; 141(6):1503-12. PubMed ID: 21463876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.
    Guleng B; Tateishi K; Ohta M; Kanai F; Jazag A; Ijichi H; Tanaka Y; Washida M; Morikane K; Fukushima Y; Yamori T; Tsuruo T; Kawabe T; Miyagishi M; Taira K; Sata M; Omata M
    Cancer Res; 2005 Jul; 65(13):5864-71. PubMed ID: 15994964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Positive urinary cytology in patients with lung cancer in the absence of obvious urine tract metastases.
    Voulgaris E; Pentheroudakis G; Pappa L; Bafa M; Goussia A; Dalezis P; Tsombanidou C; Geromichalos G; Papageorgiou A; Koutsilieris M; Malamou-Mitsi V; Pavlidis N
    Lung Cancer; 2011 Jul; 73(1):51-8. PubMed ID: 21111510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
    Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of autocrine CXCL12/CXCR4 system in the regulation of ovarian carcinoma cell invasion.
    Miyanishi N; Suzuki Y; Simizu S; Kuwabara Y; Banno K; Umezawa K
    Biochem Biophys Res Commun; 2010 Dec; 403(1):154-9. PubMed ID: 21059341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of CXCR4 in lung cancer metastasis and its possible mechanism].
    Su LP; Zhang JP; Xu HB; Chen J; Wang Y; Xiong SD
    Zhonghua Yi Xue Za Zhi; 2005 May; 85(17):1190-4. PubMed ID: 16029594
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repetitive nicotine exposure leads to a more malignant and metastasis-prone phenotype of SCLC: a molecular insight into the importance of quitting smoking during treatment.
    Martínez-García E; Irigoyen M; González-Moreno O; Corrales L; Teijeira A; Salvo E; Rouzaut A
    Toxicol Sci; 2010 Aug; 116(2):467-76. PubMed ID: 20457658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCR4 antagonists suppress small cell lung cancer progression.
    Taromi S; Kayser G; Catusse J; von Elverfeldt D; Reichardt W; Braun F; Weber WA; Zeiser R; Burger M
    Oncotarget; 2016 Dec; 7(51):85185-85195. PubMed ID: 27835905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T140 analogs as CXCR4 antagonists identified as anti-metastatic agents in the treatment of breast cancer.
    Tamamura H; Hori A; Kanzaki N; Hiramatsu K; Mizumoto M; Nakashima H; Yamamoto N; Otaka A; Fujii N
    FEBS Lett; 2003 Aug; 550(1-3):79-83. PubMed ID: 12935890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Focus on the role of the CXCL12/CXCR4 chemokine axis in head and neck squamous cell carcinoma.
    Albert S; Riveiro ME; Halimi C; Hourseau M; Couvelard A; Serova M; Barry B; Raymond E; Faivre S
    Head Neck; 2013 Dec; 35(12):1819-28. PubMed ID: 23468253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.